Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Developing rpa microfluidic device for rapid detection of hcv as point-of-care test .
- At: Glasgow (Scotland) (2018)
- Type: Poster
- By: ZYADA, Ebrahim (Misr University for Science and Technology, Clinical Pharmacy)
- Co-author(s): Ebrahim Mohamed Zyada: Misr University for Science and Technology, Cairo, Egypt
Shreen Helal: MSA University, Cairo, Egypt
BackgroundNucleic acid amplification is the most sensitive and specific method to detect (HCV) .However the polymerase chain reaction remains laboratory-based and has to be conducted by trained personnel , needs expensive equipment and can't be applied as point-of-care test .
MethodsThe new method depends on Recombinase Polymerase Amplification.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019